November 17, 2017 – The American Food & Drug Administration (FDA) just approved  Vestronidase alfa-vjb (Mepsevii),  the first treatment for pediatric and adult patients with the inherited metabolic condition called mucopolysaccharidosis type VII (MPS VII), also known as Sly syndrome. MPS VII …

Treatment for the rare genetic disorder MPS VII approved Read more »